Cite
BRAF -V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor.
MLA
Mastropolo, Rosemarie, et al. “BRAF -V600E-Mutated Rosai-Dorfman-Destombes Disease and Langerhans Cell Histiocytosis with Response to BRAF Inhibitor.” Blood Advances, vol. 3, no. 12, June 2019, pp. 1848–53. EBSCOhost, https://doi.org/10.1182/bloodadvances.2019000093.
APA
Mastropolo, R., Close, A., Allen, S. W., McClain, K. L., Maurer, S., & Picarsic, J. (2019). BRAF -V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor. Blood Advances, 3(12), 1848–1853. https://doi.org/10.1182/bloodadvances.2019000093
Chicago
Mastropolo, Rosemarie, Allison Close, Steven W Allen, Kenneth L McClain, Scott Maurer, and Jennifer Picarsic. 2019. “BRAF -V600E-Mutated Rosai-Dorfman-Destombes Disease and Langerhans Cell Histiocytosis with Response to BRAF Inhibitor.” Blood Advances 3 (12): 1848–53. doi:10.1182/bloodadvances.2019000093.